BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Company Registration Number:
14158063 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2025

Period of accounts

Start date: 1 January 2025

End date: 31 December 2025

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2025

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Directors' report period ended 31 December 2025

The directors present their report with the financial statements of the company for the period ended 31 December 2025

Principal activities of the company

The Company’s principal activity during the year under review was that of an investment holding company.



Directors

The director shown below has held office during the whole of the period from
1 January 2025 to 31 December 2025

Paul O'Neill


The director shown below has held office during the period of
1 January 2025 to 25 September 2025

Christopher Bond


The director shown below has held office during the period of
25 September 2025 to 31 December 2025

James Sermon


Secretary NSM Corporate Services Limited

The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
24 August 2026

And signed on behalf of the board by:
Name: Paul O'Neill
Status: Director

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Profit And Loss Account

for the Period Ended 31 December 2025

2025 18 months to 31 December 2024


£

£
Administrative expenses: ( 11,631 )
Operating profit(or loss): (11,631)
Interest receivable and similar income: 23,864
Interest payable and similar charges: ( 22,547 )
Profit(or loss) before tax: (22,547) 12,233
Profit(or loss) for the financial year: (22,547) 12,233

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Balance sheet

As at 31 December 2025

Notes 2025 18 months to 31 December 2024


£

£
Fixed assets
Intangible assets: 3 459,023 459,023
Total fixed assets: 459,023 459,023
Creditors: amounts falling due within one year: 4 ( 470,677 ) ( 448,130 )
Net current assets (liabilities): (470,677) (448,130)
Total assets less current liabilities: (11,654) 10,893
Total net assets (liabilities): (11,654) 10,893
Capital and reserves
Called up share capital: 1 1
Profit and loss account: (11,655 ) 10,892
Total Shareholders' funds: ( 11,654 ) 10,893

The notes form part of these financial statements

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Balance sheet statements

For the year ending 31 December 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 August 2026
and signed on behalf of the board by:

Name: Paul O'Neill
Status: Director

The notes form part of these financial statements

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Intangible fixed assets amortisation policy

    Intangible assets comprises of intellectual property that is held for its investment potential, it is included in the balance sheet at cost. Consideration will be given for annual impairment reviews and carried out if deemed appropriate and economically viable.

    Other accounting policies

    Foreign Currencies - The financial statements have been prepared in Sterling, the reporting currency of the Company. Assets and liabilities in other currencies are translated into Sterling at the rate of exchange ruling at the balance sheet date whilst transactions in other currencies are translated into Sterling at the rate of exchange ruling at the date of the transaction. Gains or losses on currency exchange are recognised in the profit and loss account. Ultimate controlling party - The immediate parent company is Hanscan Holdings Limited, a company registered in Guernsey. The ultimate controlling party is Liberation Management Limited as trustee of the Impulse Trust, a trust based in Guernsey.

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

  • 2. Employees

    2025 18 months to 31 December 2024
    Average number of employees during the period 0 0

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

3. Intangible assets

Goodwill Other Total
Cost £ £ £
At 1 January 2025 459,023 0 459,023
Additions
Disposals
Revaluations
Transfers
At 31 December 2025 459,023 0 459,023
Amortisation
At 1 January 2025 0 0 0
Charge for year
On disposals
Other adjustments
At 31 December 2025 0 0 0
Net book value
At 31 December 2025 459,023 0 459,023
At 31 December 2024 459,023 0 459,023

BIOCRYPTOLOGY HOLDINGS (UK) LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2025

4. Creditors: amounts falling due within one year note

2025 18 months to 31 December 2024
£ £
Other creditors 470,677 448,130
Total 470,677 448,130